CHCHD2 and metabolic dysfunction-associated steatohepatitis: Coiled-coil-helix-coiled-coil-helix domain-containing 2 (CHCHD2) is upregulated via YAP/TAZ-TEAD in NASH livers and consequently promotes liver fibrosis by activating the NOTCH pathway and enhancing OPN production [51].